ZA881181B - Process for preparing a retard product containing diltiazem for a single daily administration - Google Patents

Process for preparing a retard product containing diltiazem for a single daily administration

Info

Publication number
ZA881181B
ZA881181B ZA881181A ZA881181A ZA881181B ZA 881181 B ZA881181 B ZA 881181B ZA 881181 A ZA881181 A ZA 881181A ZA 881181 A ZA881181 A ZA 881181A ZA 881181 B ZA881181 B ZA 881181B
Authority
ZA
South Africa
Prior art keywords
preparing
product containing
daily administration
single daily
diltiazem
Prior art date
Application number
ZA881181A
Inventor
Barth Dieter
Original Assignee
Varnel Chem Business Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Varnel Chem Business Sa filed Critical Varnel Chem Business Sa
Publication of ZA881181B publication Critical patent/ZA881181B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A process is described for the preparation of a solid dosage form for oral administration in hard gelatin capsules containing pellets based on diltiazem, with controlled liberation "in vitro" of the active substance, such that a slow release and a prolonged absorption "in vivo" are possible with blood levels which are active following administration of a single dose of 180 mg every 24 hours, preferably in combination with a proportionately variable quantity of immediate-release pellets in order to obtain good blood levels even in the initial phase of absorption. <IMAGE>
ZA881181A 1987-02-20 1988-02-19 Process for preparing a retard product containing diltiazem for a single daily administration ZA881181B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH63787 1987-02-20

Publications (1)

Publication Number Publication Date
ZA881181B true ZA881181B (en) 1988-08-16

Family

ID=4191649

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA881181A ZA881181B (en) 1987-02-20 1988-02-19 Process for preparing a retard product containing diltiazem for a single daily administration

Country Status (12)

Country Link
EP (1) EP0282698B1 (en)
JP (1) JP2863528B2 (en)
KR (1) KR960011232B1 (en)
AT (1) ATE172112T1 (en)
AU (1) AU1196988A (en)
BR (1) BR8800763A (en)
CA (1) CA1327006C (en)
DE (1) DE3856258T2 (en)
DK (1) DK173505B1 (en)
ES (1) ES2125215T3 (en)
MX (1) MX10490A (en)
ZA (1) ZA881181B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737741A1 (en) * 1987-11-06 1989-05-18 Goedecke Ag ORAL MEDICAL FORM FOR THE ONLY DAILY TREATMENT OF HYPERTENSION WITH DILTIAZEMHYDROCHLORIDE
DE3922167A1 (en) * 1988-04-16 1991-01-17 Sanol Arznei Schwarz Gmbh Oral diltiazem hydrochloride dosage forms - for admin. once a day, contg. fast- and delayed-release components
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
SE8902699D0 (en) * 1989-08-09 1989-08-09 Lejus Medical Ab DILTIAZEM CONTAINING PHARMACEUTICAL COMPOSITIOS
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
JP3746315B2 (en) 1994-07-07 2006-02-15 ダイセル化学工業株式会社 Separating agent
US5834024A (en) 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2742660B1 (en) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques NOVEL FORMS OF EXTENDED RELEASE MICROGRANULES CONTAINING DILTIAZEM AS ACTIVE INGREDIENT
CN100475210C (en) * 1996-03-08 2009-04-08 尼科梅德丹麦有限公司 Modified release multiple-units dosage composition
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
FR2754710B1 (en) * 1996-10-22 1998-12-31 Prographarm Lab PROCESS FOR THE PREPARATION OF A MULTIPARTICULAR PHARMACEUTICAL FORM WITH CONTROLLED RELEASE PLURISEQUENTIELLE
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
AU736329B2 (en) 1998-06-22 2001-07-26 Asahi Kasei Kabushiki Kaisha Porous polyvinylidene fluoride resin membrane and process for preparing the same
US7108866B1 (en) * 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
JPS5867616A (en) * 1981-10-15 1983-04-22 Tanabe Seiyaku Co Ltd Enteric microcapsule and its preparation
JPS604120A (en) * 1983-06-22 1985-01-10 Shionogi & Co Ltd Pharmaceutical preparation of pinacidil of long acting type
FR2554718B1 (en) * 1983-11-14 1986-04-04 Ethypharm Sa NEW ORAL SULPIRIDE FORMS FOR SULPIRIDE
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1178511B (en) * 1984-09-14 1987-09-09 Pharmatec Spa PROCEDURE FOR THE PREPARATION OF A SOLID FORM FOR ORAL USE BASED ON NIFEDIPINE WITH RELEASE

Also Published As

Publication number Publication date
EP0282698A1 (en) 1988-09-21
BR8800763A (en) 1988-10-04
JP2863528B2 (en) 1999-03-03
DK15388D0 (en) 1988-01-13
DK173505B1 (en) 2001-01-15
DK15388A (en) 1988-08-21
ATE172112T1 (en) 1998-10-15
AU1196988A (en) 1988-08-25
DE3856258D1 (en) 1998-11-19
DE3856258T2 (en) 1999-04-29
MX10490A (en) 1993-12-01
KR880009640A (en) 1988-10-04
ES2125215T3 (en) 1999-03-01
JPH01216934A (en) 1989-08-30
EP0282698B1 (en) 1998-10-14
KR960011232B1 (en) 1996-08-21
CA1327006C (en) 1994-02-15

Similar Documents

Publication Publication Date Title
ZA881181B (en) Process for preparing a retard product containing diltiazem for a single daily administration
US4193985A (en) Multiple-units drug dose
UA29563C2 (en) Microcapsule for prolonged release of physiologically active peptide
HUT45194A (en) Process for production of medical composition
IL96900A0 (en) Pharmaceutical composition containing naproxen
ES8307095A1 (en) Pharmaceutical Formulation.
KR860001591A (en) Pellet Formulations and Methods for Making the Same
PH23993A (en) Controlled absorption pharmaceutical composition
AP9400645A0 (en) Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release sold dosage forms of medicaments prepared thereby.
GR3031028T3 (en) Improved pulsatile once-a-day delivery systems for minocycline
IL77186A0 (en) Pharmaceutical insulin composition
MY125662A (en) Pharmaceutical formulations containing darifenacin
NL193440C (en) Pharmaceutical preparation with analgesic effect.
JP2893307B2 (en) Pharmaceutical stable formulation of Nicorandil
FI89238C (en) Process for preparing compression-coated tablets
HK134494A (en) Substituted release azelastine containing medicaments
PL317996A1 (en) Carbamazepinic form of a drug with retarded release of biologically active substance
US3362879A (en) Tyrosine tranquilizing compositions and methods of treatment
ES500670A0 (en) PROCEDURE FOR PREPARING DRUGS WITH A PROGRAMMED RELEASE OF ACTIVE SUBSTANCE.
HK1001822A1 (en) Medicinal form for oral application for the once-a-day treatment of hypertension by diltiazem hydrochloride
RU96123569A (en) MEDICINAL PRODUCT
MY114610A (en) Controlled drug delivery system for diltiazem.